[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2005903196A0 - Pharmaceutical formulation - Google Patents

Pharmaceutical formulation

Info

Publication number
AU2005903196A0
AU2005903196A0 AU2005903196A AU2005903196A AU2005903196A0 AU 2005903196 A0 AU2005903196 A0 AU 2005903196A0 AU 2005903196 A AU2005903196 A AU 2005903196A AU 2005903196 A AU2005903196 A AU 2005903196A AU 2005903196 A0 AU2005903196 A0 AU 2005903196A0
Authority
AU
Australia
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2005903196A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mayne Pharma Pty Ltd
Original Assignee
Mayne Pharma Pty Ltd
Filing date
Publication date
Application filed by Mayne Pharma Pty Ltd filed Critical Mayne Pharma Pty Ltd
Publication of AU2005903196A0 publication Critical patent/AU2005903196A0/en
Assigned to MAYNE PHARMA LTD reassignment MAYNE PHARMA LTD Request for Assignment Assignors: Maybe Pharma Pty Ltd
Priority to PCT/AU2006/000843 priority Critical patent/WO2006133510A1/en
Priority to EP09012526A priority patent/EP2138164A1/en
Priority to EP10015393A priority patent/EP2308467A3/en
Priority to CA002611592A priority patent/CA2611592A1/en
Priority to KR1020087001355A priority patent/KR20080030024A/en
Priority to AU2006257718A priority patent/AU2006257718A1/en
Priority to US11/922,165 priority patent/US20090118354A1/en
Priority to SG201004237-2A priority patent/SG162798A1/en
Priority to JP2008516077A priority patent/JP2008543789A/en
Priority to EP06741249A priority patent/EP1904052A4/en
Priority to TW095122383A priority patent/TW200800159A/en
Priority to IL187957A priority patent/IL187957A0/en
Priority to US13/038,623 priority patent/US20110152360A1/en
Abandoned legal-status Critical Current

Links

AU2005903196A 2005-06-17 2005-06-17 Pharmaceutical formulation Abandoned AU2005903196A0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
JP2008516077A JP2008543789A (en) 2005-06-17 2006-06-16 Docetaxel liquid pharmaceutical formulation
EP06741249A EP1904052A4 (en) 2005-06-17 2006-06-16 Liquid pharmaceutical formulations of docetaxel
AU2006257718A AU2006257718A1 (en) 2005-06-17 2006-06-16 Liquid pharmaceutical formulations of docetaxel
SG201004237-2A SG162798A1 (en) 2005-06-17 2006-06-16 Liquid pharmaceutical formulations of docetaxel
EP10015393A EP2308467A3 (en) 2005-06-17 2006-06-16 Liquid pharmaceutical formulations of docetaxel
CA002611592A CA2611592A1 (en) 2005-06-17 2006-06-16 Liquid pharmaceutical formulations of docetaxel
KR1020087001355A KR20080030024A (en) 2005-06-17 2006-06-16 Pharmaceutical Liquid Formulations of Docetaxel
PCT/AU2006/000843 WO2006133510A1 (en) 2005-06-17 2006-06-16 Liquid pharmaceutical formulations of docetaxel
US11/922,165 US20090118354A1 (en) 2005-06-17 2006-06-16 Liquid Pharmaceutical Formulations of Docetaxel
EP09012526A EP2138164A1 (en) 2005-06-17 2006-06-16 Liquid pharmaceutical formulations of docetaxel
TW095122383A TW200800159A (en) 2005-06-17 2006-06-21 Pharmaceutical formulation
IL187957A IL187957A0 (en) 2005-06-17 2007-12-06 Liquid pharmaceutical formulations of docetaxel
US13/038,623 US20110152360A1 (en) 2005-06-17 2011-03-02 Liquid pharmaceutical formulations of docetaxel

Publications (1)

Publication Number Publication Date
AU2005903196A0 true AU2005903196A0 (en) 2005-06-30

Family

ID=

Similar Documents

Publication Publication Date Title
AU2013257508A1 (en) Pharmaceutical compositions
GB0614586D0 (en) Pharmaceutical Formulation
EP1755682A4 (en) Solid pharmaceutical formulation
EP1864664A4 (en) Pharmaceutical preparation
AU2005903196A0 (en) Pharmaceutical formulation
AU2005904737A0 (en) Drug formulation
GB0522473D0 (en) A pharmaceutical formulation
HK1119909A (en) Pharmaceutical formulations
AU2004902190A0 (en) Pharmaceutical Formulation
AU2006903259A0 (en) Pharmaceutical formulation
HK1115809A (en) Pharmaceutical composition
GB0515937D0 (en) Pharmaceutical formulation
HK1123973A (en) Pharmaceutical compositions
HK1118725A (en) Pharmaceutical formulations
HK1133832A (en) Pharmaceutical formulations
HK1117423A (en) Pharmaceutical formulations
HK1118726A (en) Pharmaceutical formulations
HK1102292A (en) Pharmaceutical compositions
HK1103620A (en) Pharmaceutical formulations
HK1120207A (en) Solid vaccine formulation
AU2004901779A0 (en) Pharmaceutical composition
AU2007905870A0 (en) Pharmaceutical formulation
GB0418270D0 (en) Pharmaceutical formulation
GB0422111D0 (en) Pharmaceutical formulation
AU2005902070A0 (en) p53 Formulation